I certainly could be wrong, but I read it as there was information in the submission that could be interpreted more than one way, and needed "clarification". Not we need a whole new set of data submitted to create more information for a decision. But I neither work in the medical field nor the FDA. I believe it to be a simple clarification as stated and backed up by the positive comments of Ichim.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.